Evidence for the Role of the Brain-Gut Axis in Inflammatory Bowel Disease: Depression as Cause and Effect?

Gastroenterology

Volumn 136, Issue 7, 2009, Pages 2058-2061

  Taché, Yvette ^a   Bernstein, Charles N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; INFLIXIMAB; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; BRAIN; COLITIS; CONSENSUS; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; EDITORIAL; ENTERITIS; GASTROENTEROLOGY; GENETIC PREDISPOSITION; HUMAN; INTESTINE; MAJOR DEPRESSION; MENTAL HEALTH; MOOD DISORDER; NONHUMAN; PANIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION;

EID: 66449094404     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.032     Document Type: Editorial

References (27)

1. Graff L.A., Walker J.R., Bernstein C.N., et al. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis (2009) Epub ahead of print
2. North C.S., and Alpers D.H. A review of studies of psychiatric factors in Crohn's disease: etiologic implications. Ann Clin Psychiatry 6 (1994) 117-124
3. Walker J.R., Ediger J.P., Graff L.A., et al. The Manitoba IBD Cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 103 (2008) 1989-1997
4. Kessler R.C., Merikangas K.R., Berglund P., et al. Mild disorders should not be eliminated from the DSM-V. Arch Gen Psych 60 (2003) 1117-1122
5. Rosenkranz M.A. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol Bull 133 (2007) 1007-1037
6. Rook G.A.W., and Lowry C.A. The hygiene hypothesis and psychiatric disorders. Trends Immun 29 (2008) 150-158
7. Ghia J., Blennerhassett P., and Collins S.M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 188 (2008) 2209-2218
8. Kurina L.M., Goldacre M.J., Yeates D., et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 55 (2001) 716-720
9. Lerebours E., Gower-Rousseau C., Merle V., et al. Stress life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am J Gastroenterol 102 (2007) 122-131
10. Fuller-Thomson E., and Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 12 (2006) 697-707
11. Mittermaier C., Dejaco C., Waldhoer T., et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66 (2004) 79-84
12. Persoons P., Vermeire S., Demyttenaere K., et al. The impact of major depressive disorder on the short- and long term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther 22 (2005) 101-110
13. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
14. Ghia J.E., Blennerhassett P., Deng Y., et al. Re-activation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 136 (2009) 2280-2288
15. Takahashi K., Saitoh A., Yamada M., et al. Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants. J Pharmacol Sci 108 (2008) 320-334
16. Ghia J.E., Blennerhassett P., and Collins S.M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 118 (2008) 2209-2218
17. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
18. Van Der Zanden E.P., Boeckxstaens G.E., and de Jonge W.J. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 21 (2009) 6-17
19. Ilnyckyj A., and Bernstein C.N. Sexual abuse in irritable bowel syndrome: to ask or not to ask, that is the question. Can J Gastroenterol 16 (2002) 801-806
20. Mulrow C.D., Williams Jr. J.W., Gerety M.B., et al. Case-finding instruments for depression in primary care settings. Ann Intern Med 123 (1995) 913-921
21. Means-Christensen A.J., Sherbourne C.D., Roy-Byrne P.P., et al. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry 28 (2006) 108-118
22. Caprilli R., Gassull M.A., Escher J.C., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 Suppl 1 (2006) 36-58
23. Ford A.C., Talley N.J., Schoenfeld P.S., et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58 (2009) 367-378
24. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., et al. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health 2 (2006) 1-9
25. Sareen J., Jacobi F., Cox B.J., et al. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 166 (2006) 2109-2116
26. Sharma P., Makharia G.K., Ahuja V., et al. Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission. Dig Dis Sci 54 (2009) 853-861
27. Carney R.M., Freedland K.E., and Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67 Suppl 1 (2005) S29-S33